pramlintide-Fc-Leptin fusion protein (Amprotein)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namepramlintide-Fc-Leptin fusion protein (Amprotein)
Drug Alias Namepramlintide-Fc-LeptinAMPSL
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionLeptin receptor agonistsGlucagon-like peptide 1 receptor agonistsAmylin receptor agonists
TargetsLeptin receptorGlucagon-like peptide 1 receptorAmylin Receptor
Therapy Area/IndicationsObesityDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmProtein Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmProtein Corp
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A